BRPI0819338A2 - Preparações, métodos e kits úteis para o tratamento de tosse - Google Patents

Preparações, métodos e kits úteis para o tratamento de tosse

Info

Publication number
BRPI0819338A2
BRPI0819338A2 BRPI0819338-0A BRPI0819338A BRPI0819338A2 BR PI0819338 A2 BRPI0819338 A2 BR PI0819338A2 BR PI0819338 A BRPI0819338 A BR PI0819338A BR PI0819338 A2 BRPI0819338 A2 BR PI0819338A2
Authority
BR
Brazil
Prior art keywords
kits
useful
methods
cough preparations
cough
Prior art date
Application number
BRPI0819338-0A
Other languages
English (en)
Inventor
Stephen Andras Kovacs
Jeffrey Alan Sargent
Helen Rochelle Kemp
Kristin Rhedrick Williams
Mary Lynn Jump
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BRPI0819338A2 publication Critical patent/BRPI0819338A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0819338-0A 2007-11-21 2008-11-20 Preparações, métodos e kits úteis para o tratamento de tosse BRPI0819338A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US388607P 2007-11-21 2007-11-21
US2854708P 2008-02-14 2008-02-14
PCT/IB2008/054886 WO2009066262A1 (en) 2007-11-21 2008-11-20 Preparations, methods and kits useful for treatment of cough

Publications (1)

Publication Number Publication Date
BRPI0819338A2 true BRPI0819338A2 (pt) 2015-05-19

Family

ID=40303655

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0819819-5A BRPI0819819A2 (pt) 2007-11-21 2008-11-20 Preparações, método e kits ùteis para o tratamento de tosse
BRPI0819338-0A BRPI0819338A2 (pt) 2007-11-21 2008-11-20 Preparações, métodos e kits úteis para o tratamento de tosse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BRPI0819819-5A BRPI0819819A2 (pt) 2007-11-21 2008-11-20 Preparações, método e kits ùteis para o tratamento de tosse

Country Status (11)

Country Link
US (3) US20090155189A1 (pt)
EP (2) EP2219677A1 (pt)
JP (1) JP2011504184A (pt)
CN (2) CN101868252A (pt)
AU (1) AU2008326386B2 (pt)
BR (2) BRPI0819819A2 (pt)
CA (2) CA2706472A1 (pt)
ES (1) ES2655477T3 (pt)
MX (2) MX2010005642A (pt)
RU (1) RU2476240C2 (pt)
WO (2) WO2009066262A1 (pt)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0921011A8 (pt) * 2008-11-13 2017-07-11 Xeros Pharmaceuticals Llc Métodos para preparar uma composição oral tópica, e, produto para cuidado oral
CA2649936A1 (en) 2009-01-15 2010-07-15 John Lawrence Rowe Honey product having a low water content
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
US20110195042A1 (en) * 2010-02-10 2011-08-11 Thomas Edward Huetter Compositions, Methods and Kits Useful for Treating a Respiratory Symptom
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US10085938B2 (en) * 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US9987224B2 (en) * 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US8992893B2 (en) 2011-04-19 2015-03-31 Arms Pharmaceutical, Llc Method of inhibiting harmful microorganisms and barrier-forming composition therefor
US10426761B2 (en) 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
KR101915056B1 (ko) * 2012-04-10 2018-11-07 한미약품 주식회사 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법
US8771651B2 (en) * 2012-09-10 2014-07-08 Johnson & Johnson Consumer Companies, Inc. Mouth rinses and tooth sensitivity treatment compositions
DE202013000445U1 (de) * 2012-10-04 2013-10-07 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung, insbesondere pharmazeutische Zusammensetzung, insbesondere zur Verabreichung bei Heiserkeit
PL2908831T3 (pl) * 2012-10-17 2018-07-31 Montero Gida Sanayi Ve Ticaret A.S. Preparaty ziołowe
SI2908834T1 (sl) * 2012-10-17 2017-12-29 Montero Gida Sanayi Ve Ticaret A.S. Nove formulacije, ki obsegajo rastlinske ekstrakte
WO2014107221A1 (en) * 2013-01-04 2014-07-10 ARMS Pharmaceutical LLC Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
ES2795291T3 (es) 2013-02-13 2020-11-23 Procter & Gamble Medicamento con sabor a anís
US20140294990A1 (en) * 2013-03-27 2014-10-02 Timothy P. O'Connor Throat gargle tablet and method of use thereof
CN103432029B (zh) * 2013-08-15 2016-02-17 金红叶纸业集团有限公司 组合物及应用其的纸巾
ITRM20130592A1 (it) * 2013-10-25 2015-04-26 Aboca Spa Societa Agricola Composizione per la tosse.
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
CN103875802B (zh) * 2014-04-15 2015-04-08 厦门绿链集成服务有限公司 一种新鲜水果的保鲜方法
CN107028987A (zh) * 2017-04-11 2017-08-11 成都吉氧屋科技有限公司 一种微生物黏附率调节剂及其应用
US11007171B2 (en) * 2017-07-13 2021-05-18 Summit Innovation Labs, LLC Treatment and prevention of joint disorders
FR3074688B1 (fr) 2017-12-13 2020-07-10 Roquette Freres Systeme epaississant et stabilisant d'origine naturelle convenant notamment a la preparation de produits cosmetiques
US11273123B2 (en) 2018-07-18 2022-03-15 USpharma Ltd Chewable pharmaceutical dosage forms
US20220047627A1 (en) * 2018-10-22 2022-02-17 Cmpd Licensing, Llc Non-infective nasal symptom management compositions and methods
US20220062173A1 (en) * 2019-01-08 2022-03-03 Johnson & Johnson Consumer Inc. Liquid compositions
CN112439072A (zh) * 2019-08-29 2021-03-05 鲁南制药集团股份有限公司 一种掩味组合物及其制备方法、用途
CN116726054B (zh) * 2022-12-05 2024-03-26 山东新时代药业有限公司 一种即食型益生菌组合物及其制备方法、用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1121358A (en) * 1965-10-21 1968-07-24 Bristol Myers Co Aerosol manufacture
US4029797A (en) * 1973-06-20 1977-06-14 Fisons Corporation Process of making cough syrup with masked noscapine
US4427681A (en) * 1982-09-16 1984-01-24 Richardson-Vicks, Inc. Thixotropic compositions easily convertible to pourable liquids
EP0306469B1 (en) 1987-09-04 1992-03-04 The Procter & Gamble Company Psyllium-containing filling compositions
EP0387933B1 (en) 1989-03-16 1993-08-04 The Procter & Gamble Company High fiber baked cookies containing psyllium
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
US5296209A (en) 1992-01-17 1994-03-22 Colgate Palmolive Company Pet chew product having oral care properties
EP0620001A1 (en) * 1993-04-16 1994-10-19 McNEIL-PPC, INC. Aqueous pharmaceutical suspension and process for preparation thereof
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
WO1996021432A1 (en) * 1995-01-11 1996-07-18 Cygnus, Inc. Delivery of active substances by way of mucosal surfaces of pharyngeal and esophageal regions
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
WO1996039116A1 (en) * 1995-06-05 1996-12-12 Whitehill Oral Technologies, Inc. Oral care ultramulsion based products
FR2741535B1 (fr) * 1995-11-28 1998-12-24 Sun Trading Ltd Nouvelles preparations pour la sphere bucco-pharyngee
FR2757022B1 (fr) * 1996-12-13 1999-03-05 Bel Fromageries Nouveau procede d'enrobage pour produits alimentaires et les produits enrobes obtenus
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
GB2328443B (en) * 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
US6599883B1 (en) * 1998-10-30 2003-07-29 Nastech Pharmaceutical Company, Inc. Nasal delivery of xylitol
GB9827355D0 (en) * 1998-12-11 1999-02-03 Biochemie Sa Organic compounds
US6230052B1 (en) * 1999-01-29 2001-05-08 Andy Wolff Device and method for stimulating salivation
IN186667B (pt) 1999-01-29 2001-10-20 Ajanta Pharma Ltd
ES2282247T3 (es) * 2000-04-28 2007-10-16 Inflazyme Pharmaceuticals, Ltd. Esteroides 3-nitrogeno-6,7-dioxigenados y usos relacionados con ellos.
KR100945342B1 (ko) * 2001-04-30 2010-03-08 밀람 미이거 벤 직물의 실링장치
US6696047B2 (en) * 2001-09-13 2004-02-24 The Procter & Gamble Company Stable oral care compositions comprising chlorite
US7138133B2 (en) * 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
US20030170371A1 (en) 2002-01-10 2003-09-11 Cargill, Inc. High fat/fiber composition
US20060193959A1 (en) 2002-10-30 2006-08-31 Li Nie Low calorie injection molded starch-based pet chew bodies
US20050214349A1 (en) 2002-10-30 2005-09-29 Li Nie Extruded gluten based pet chew bodies
WO2004045537A2 (en) * 2002-11-14 2004-06-03 Zengen, Inc. Edible film for relief of cough or symptoms associated with pharyngitis
DE10253331A1 (de) * 2002-11-14 2004-06-03 Symrise Gmbh & Co. Kg Verwendung von trans-Pellitori als Aromastoff
DE10261061A1 (de) 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
EP1583559B1 (en) 2003-01-13 2010-04-07 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
WO2004084637A1 (en) 2003-03-24 2004-10-07 Council Of Scientific And Industrial Research A high fibre biscuit composition and a process for preparing the same
EP1635647B1 (en) * 2003-06-05 2010-05-12 Avebe America, Inc. Instantly dispersible pregelatinized starches for use in food products
US7118772B2 (en) 2003-09-18 2006-10-10 General Mills, Inc. Inulin infused fruit and method of preparation
EP1679974A4 (en) 2003-11-07 2008-07-30 Mgp Ingredients Inc COMPOSITION AND PROCESS FOR THE PREPARATION OF FOOD PRODUCTS WITH HIGH PROTEIN CONTENT AND LOW CARBOHYDRATE CONTENT
US20060039973A1 (en) 2004-08-19 2006-02-23 Mary Aldritt Effervescent composition including water soluble dietary fiber
US20060120967A1 (en) * 2004-12-07 2006-06-08 Qpharma, Llc Solution forms of cyclodextrins for nasal or throat delivery of essential oils
US20060188450A1 (en) 2005-02-24 2006-08-24 Tim Clarot System and method for suppressing a cough
US20070042023A1 (en) * 2005-08-22 2007-02-22 National Starch And Chemical Investment Holding Corporation Dissolvable film
US20070048424A1 (en) * 2005-09-01 2007-03-01 Moza Ashok K Liquid composition of 2-Isopropyl-N,2,3-trimethylbutyramide and N-Ethyl-p-menthane-3-carboxamide, its preparation method and its applications as a cooling agent and flavor enhancer
US20070148283A1 (en) 2005-12-23 2007-06-28 Cadbury Adams Usa Llc Compositions providing a sensation substantially similar to that provided by menthol
WO2007089652A2 (en) 2006-01-27 2007-08-09 Cadbury Adams Usa Llc Flavor-enhancing compositions, methods of manufacture, and methods of use
US9005652B2 (en) * 2006-07-25 2015-04-14 Wyeth Chewable tablet containing phenylephrine

Also Published As

Publication number Publication date
RU2476240C2 (ru) 2013-02-27
CA2706440C (en) 2014-03-25
RU2010116996A (ru) 2011-12-27
EP2217279B1 (en) 2017-11-01
US20090130199A1 (en) 2009-05-21
WO2009067605A3 (en) 2010-02-11
US20090155189A1 (en) 2009-06-18
MX2010005642A (es) 2010-07-30
CA2706472A1 (en) 2009-05-28
CN101868253A (zh) 2010-10-20
EP2219677A1 (en) 2010-08-25
WO2009066262A1 (en) 2009-05-28
MX337194B (es) 2016-02-15
CN101868252A (zh) 2010-10-20
CA2706440A1 (en) 2009-05-28
AU2008326386A1 (en) 2009-05-28
WO2009067605A2 (en) 2009-05-28
US9149429B2 (en) 2015-10-06
ES2655477T3 (es) 2018-02-20
EP2217279A2 (en) 2010-08-18
AU2008326386B2 (en) 2014-07-31
BRPI0819819A2 (pt) 2015-05-26
MX2010005643A (es) 2010-07-30
JP2011504184A (ja) 2011-02-03
US20160000925A1 (en) 2016-01-07

Similar Documents

Publication Publication Date Title
BRPI0819338A2 (pt) Preparações, métodos e kits úteis para o tratamento de tosse
CY2016005I2 (el) Αλκαλικη φωσφαταση στοχευμενη στα οστα, κιτ και μεθοδοι χρησης αυτων
BRPI0809573A8 (pt) composição, e, método
FI20075269A0 (fi) Menetelmä ja järjestely antennin sovittamiseksi
BRPI0817292A2 (pt) Método e aparelho para completação de poços.
BRPI0923159A2 (pt) gene de delta-endotoxina axmi-150 e métodos para sua utilização.
BRPI0821276A2 (pt) Produto, e, uso do produto
BRPI0909770A2 (pt) Vacina, e, kit
FI20065348A0 (fi) Spektrometri ja inferferometrinen menetelmä
BRPI0814330A2 (pt) métodos e kits cirúrgicos
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
BRPI0919575A2 (pt) método, e, composição
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
FI20075978A0 (fi) Järjestely ja menetelmä
BRPI0815887A2 (pt) Uso de conduto metálico, processo e duto subterrâneo.
BRPI0916121A8 (pt) métodos para identificar câncer de próstata, composição, kit, método para identificar a presença de uma fusão gênica e uso de uma composição
BRPI0813969A2 (pt) Método para tingir permanentemente o cabelo, e, kit para tingir em substrato queratinoso.
BRPI0816063A2 (pt) Garrafas retráteis e métodos para uso do mesmo
BR112012000735A2 (pt) "métodos, kits e conjuntos de compostos"
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0822296A2 (pt) Transponder e livreto
BRPI0814167A2 (pt) Composição, e, método
BRPI0823277A2 (pt) Composição, e , método
BRPI0614961A2 (pt) aptâmero, método, e, composição
BRPI0921960A2 (pt) granulado de pigmento, método para produzir o mesmo e uso do mesmo

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.